Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Flotetuzumab demonstrated 29.4% complete response rate in evaluable primary refractory AML patientsTranslational studies suggest ...
– Larotrectinib Rolling NDA Submission on Track for Completion in March – – LOXO-292 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email